본문 바로가기
KERD
논문KCI 등재

‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Although believed safer compared to short-acting benzodiazepines (BZD), in the past few years a growing concern has developed relating to the abuse of Z-drugs, and specifically of zolpidem. Here we aim to review the evidence for the misuse of zolpidem and describe several related cases collected in Italy. A comprehensive overview is here carried by using several databases, and by combining the search strategy of free text terms and exploding a range of MESH headings relating to the topics of Zolpidem and Abuse and/or Misuse as follows: ((Zolpidem[Title/Abstract]) AND (Abuse[Title/Abstract]) OR (Misuse[Title/Abstract])), without time and/or language restrictions. Furthermore, a case series of 8 cases of zolpidem misuse and/or abuse, collected in different Italian psychiatric settings (psychiatric public hospital, psychiatric private rehabilitation clinic, and private practice), have been here described. According to our findings, zolpidem should be prescribed with the same caution as BZDs, especially in patients with a history of drug abuse or in the elderly. Behavioural modifications, including bizarre behaviours, psychomotor agitation, sleep-related complex behaviours have been reported. Monitoring of zolpidem use in selected populations is warranted. Psychiatrists and physicians should be aware of the misuse potential of zolpidem and adopt measures restricting its use.

Abstract

Although believed safer compared to short-acting benzodiazepines (BZD), in the past few years a growing concern has developed relating to the abuse of Z-drugs, and specifically of zolpidem. Here we aim to review the evidence for the misuse of zolpidem and describe several related cases collected in Italy. A comprehensive overview is here carried by using several databases, and by combining the search strategy of free text terms and exploding a range of MESH headings relating to the topics of Zolpidem and Abuse and/or Misuse as follows: ((Zolpidem[Title/Abstract]) AND (Abuse[Title/Abstract]) OR (Misuse[Title/Abstract])), without time and/or language restrictions. Furthermore, a case series of 8 cases of zolpidem misuse and/or abuse, collected in different Italian psychiatric settings (psychiatric public hospital, psychiatric private rehabilitation clinic, and private practice), have been here described. According to our findings, zolpidem should be prescribed with the same caution as BZDs, especially in patients with a history of drug abuse or in the elderly. Behavioural modifications, including bizarre behaviours, psychomotor agitation, sleep-related complex behaviours have been reported. Monitoring of zolpidem use in selected populations is warranted. Psychiatrists and physicians should be aware of the misuse potential of zolpidem and adopt measures restricting its use.

참고문헌 (103)

  1. Guidance on the use of zaleplon, zolpidem and zopiclone for the shortterm management of insomnia, "National Institute for Health and Care Excellence (NICE)", National Institute for Health and Care Excellence (NICE), ~ (2004)
  2. Marsden J, "Medicines associated with dependence or withdrawal : a mixed-methods public health review and national database study in England", Lancet Psychiatry, 6, pp.935~950 (2019)
  3. Wilson S, "British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders : an update", J Psychopharmacol, 33, pp.923~947 (2019)
  4. Swainston Harrison T, "Zolpidem : a review of its use in the management of insomnia", CNS Drugs, 19, pp.65~89 (2005)
  5. Siriwardena AN, "GPs’ attitudes to benzodiazepine and ‘Z-drug’ prescribing : a barrier to implementation of evidence and guidance on hypnotics", Br J Gen Pract, 56, pp.964~967 (2006)
  6. "Guidance on appropriate prescribing of benzodiazepines and z-drugs (BZRA) in the treatment of anxiety and insomnia" (2018)[URL]
  7. "Z-drugs: a review of the evidence of misuse and harm" (2013)[URL]
  8. Vozoris NT, "Benzodiazepine and opioid co-usage in the US population, 1999-2014: an exploratory analysis", Sleep, 42, pp.zsy264~ (2019)
  9. "Br J Gen Pract", 2017, e609~
  10. "Presse Med", 2018, 872~877
  11. Schonmann Y, "Chronic hypnotic use at 10 years-does the brand matter?", Eur J Clin Pharmacol, 74, pp.1623~1631 (2018)
  12. Stahl SM, "Stahl’s essential psychopharmacology: prescriber’s guide antidepressants" (2017), Cambridge University Press
  13. Gunja N, "The clinical and forensic toxicology of Z-drugs", J Med Toxicol, 9, pp.155~162 (2013)
  14. "Guidance for the use andreduction of misuse ofbenzodiazepines and otherhypnotics and anxiolytics ingeneral practice" (2014)[URL]
  15. "WHO Expert Committee on drug dependence" (2001)[URL]
  16. Rush CR, "Behavioral pharmacology of zolpidem relative to benzodiazepines : a review", Pharmacol Biochem Behav, 61, pp.253~269 (1998)
  17. Hajak G, "Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone : a review of case reports and epidemiological data", Addiction, 98, pp.1371~1378 (2003)
  18. Griffiths RR, "Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds", J Clin Psychiatry, 66(Suppl 9), pp.31~41 (2005)
  19. Victorri-Vigneau C, "An update on zolpidem abuse and dependence", J Addict Dis, 33, pp.15~23 (2014)
  20. "The misuse of benzodiazepines among high-risk opioid users in Europe" (2018)[URL]
  21. "Zolpidem"[URL]
  22. Lugoboni F, "Zolpidem high-dose abuse : what about the liver? Results from a series of 107 patients", Expert Opin Drug Saf, 18, pp.753~758 (2019)
  23. Sabe M, "Zolpidem stimulant effect : induced mania case report and systematic review of cases", Prog Neuropsychopharmacol Biol Psychiatry, 94, pp.109643~ (2019)
  24. Sharma V, "Characterisation of concurrent use of prescription opioids and benzodiazepine", Z-drugs in Alberta, Canada : a population-based study, 2019, pp.9, e030858~
  25. World drug report 2019, "United Nations Office on Drugs and Crime (UNODC)", United Nations Office on Drugs and Crime (UNODC), ~ (2019)
  26. Lin Y, "Psychiatric morbidity in dependent Z-drugs and benzodiazepine users", Int J Ment Health Addict, 15, pp.555~564 (2017)
  27. Jang Y, "Twelve-year trend in the use of zolpidem and physicians’ non-compliance with recommended duration : a Korean national health insurance database study", Eur J Clin Pharmacol, 75, pp.109~117 (2019)
  28. Cheng S, "Sociodemographic, clinical and pharmacological profiles of medication misuse and dependence in hospitalised older patients in Norway : a prospective cross-sectional study", BMJ Open, 9, pp.e031483~ (2019)
  29. Victorri-Vigneau C, "Evidence of zolpidem abuse and dependence : results of the French Centre for Evaluation and Information on Pharmacodependence(CEIP)network survey", Br J Clin Pharmacol, 64, pp.198~209 (2007)
  30. Kapil V, "Misuse of benzodiazepines and Z-drugs in the UK", Br J Psychiatry, 205, pp.407~408 (2014)
  31. Buckley NA, "Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK(1983-1999)", Drug Saf, 27, pp.135~141 (2004)
  32. Gravensteen IK, "Psychoactive substances in natural and unnatural deaths in Norway and Sweden-a study on victims of suicide and accidents compared with natural deaths in psychiatric patients", BMC Psychiatry, 19, pp.33~ (2019)
  33. Schifano F, "An insight into Z-drug abuse and dependence : an examination of reports to the European Medicines Agency database of suspected adverse drug reactions", Int J Neuropsychopharmacol, 22, pp.270~277 (2019)
  34. Shukla L, "Benzodiazepine and"Z-drug"dependence : data from a tertiary care center", Prim Care Companion CNS Disord, 16, pp.19~ (2017)
  35. Gérardin M, "French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse : ZORRO study protocol", BMJ Open, 9, pp.e027443~ (2019)
  36. Chattopadhyay AC, "High-dose zolpidem dependence-psychostimulant effects? A case report and literature review", Ind Psychiatry J, 25, pp.222~224 (2016)
  37. "FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines. Updated warnings for eszopiclone, zaleplon and zolpidem" (2019)[URL]
  38. Hyounwook Kim, "Comorbid Zolpidem Dependence and Over-the-Counter Compound Analgesic Abuse", Clinical Psychopharmacology and Neuroscience, 17(2), pp.323~325 (2019), 대한정신약물학회[DOI]
  39. Ohshima H, "Polysomnographic sleep disturbances due to high-dose zolpidem use : a case report", J Clin Sleep Med, 14, pp.1949~1952 (2018)
  40. Eslami-Shahrbabaki M, "Persistent psychosis after abuse of high dose of zolpidem", Addict Health, 6, pp.159~162 (2014)
  41. Riley DS, "CARE guidelines for case reports : explanation and elaboration document", J Clin Epidemiol, 89, pp.218~235 (2017)
  42. American Psychiatric Association (APA), "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Association
  43. Akiskal HS, "TEMPS-A : validation of a short version of a self-rated instrument designed to measure variations in temperament", J Affect Disord, 85, pp.45~52 (2005)
  44. Monti JM, "Zolpidem’s use for insomnia", Asian J Psychiatr, 25, pp.79~90 (2017)
  45. Cavallaro R, "Tolerance and withdrawal with zolpidem", Lancet, 342, pp.374~375 (1993)
  46. Madrak LN, "Zolpidem abuse", Am J Psychiatry, 158, pp.1330~1331 (2001)
  47. Hill KP, "Zolpidem-induced delirium with mania in an elderly woman", Psychosomatics, 45, pp.88~89 (2004)
  48. Spyridi S, "Zolpidem dependence in a geriatric patient : a case report", J Am Geriatr Soc, 57, pp.1962~1963 (2009)
  49. Fernandes WH, "A case of Zolpidem dependence successfully detoxified with gabapentin", Indian J Psychiatry, 55, pp.290~292 (2013)
  50. Pourshams M, "Zolpidem abuse and dependency in an elderly patient with major depressive disorder : a case report", Daru, 22, pp.54~ (2014)
  51. Yen CF, "Dependence, misuse, and beliefs regarding use of hypnotics by elderly psychiatric patients taking zolpidem, estazolam, or flunitrazepam", Asia Pac Psychiatry, 7, pp.298~305 (2015)
  52. Chiaro G, "Severe chronic abuse of zolpidem in refractory insomnia", J Clin Sleep Med, 14, pp.1257~1259 (2018)
  53. Liappas IA, "Three cases of zolpidem dependence treated with fluoxetine : the serotonin hypothesis", World J Biol Psychiatry, 4, pp.93~96 (2003)
  54. Schepis TS, "Age cohort differences in the nonmedical use of prescription zolpidem : findings from a nationally representative sample", Addict Behav, 39, pp.1311~1317 (2014)
  55. Quaglio G, "Dependence on zolpidem : two case reports of detoxification with flumazenil infusion", Int Clin Psychopharmacol, 20, pp.285~287 (2005)
  56. Svitek J, "Extensive craving in high dose zolpidem dependency", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.591~592 (2008)
  57. Licata SC, "A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females : a pilot study", Eur J Pharmacol, 598, pp.64~67 (2008)
  58. Liappas IA, "A zolpidem and cocaine abuse case report", Int J Psychiatry Clin Pract, 6, pp.217~219 (2002)
  59. Djezzar S, "Zolpidem and dextromoramide abuse with increased metabolism", Am J Addict, 15, pp.405~406 (2006)
  60. Benyamina A, "Intravenous zolpidem abuse : a case for serotonin depletion", Am J Addict, 16, pp.534~ (2007)
  61. Jana AK, "A case of zolpidem dependence successfully detoxified with clonazepam", Am J Addict, 17, pp.343~344 (2008)
  62. Liappas IA, "Zolpidem dependence case series : possible neurobiological mechanisms and clinical management", J Psychopharmacol, 17, pp.131~135 (2003)
  63. Ahmadi J, "Misuse of zolpidem to get high: a distinguished mystery", Neuropsychiatry(London), 6, pp.64~67 (2016)
  64. Rousselet M, "The French addictovigilance network clinical assessment : Z-drugs, true false twins", Expert Opin Drug Saf, 16, pp.1063~1069 (2017)
  65. Bajaj V, "A case of zolpidem dependence with extremely high daily doses", Asia Pac Psychiatry, 11, pp.e12356~ (2019)
  66. Kinnan S, "Zolpidem-induced mania in a patient with schizoaffective disorder", Psychosomatics, 52, pp.493~494 (2011)
  67. Heydari M, "Zolpidem dependence, abuse and withdrawal : a case report", J Res Med Sci, 18, pp.1006~1007 (2013)
  68. Mohapatra S, "Zolpidem dependence : a case report", East J Psychiatry, 17, pp.46~48 (2014)
  69. Sullivan G, "Zopiclone abuse in South Wales : three case reports", Human Psychopharmacol, 10, pp.351~352 (1995)
  70. Golden SA, "Zolpidem dependence and prescription fraud", Am J Addict, 9, pp.96~97 (2000)
  71. Vartzopoulos D, "Dependence on zolpidem in high dose", Int Clin Psychopharmacol, 15, pp.181~182 (2000)
  72. Keuroghlian AS, "Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work", Am J Addict, 21, pp.576~577 (2012)
  73. Kummer L, "Zolpidem misuse in two women with no psychiatric history : a crucial role of pleasant visual hallucinations", J Neuropsychiatry Clin Neurosci, 24, pp.E32~ (2012)
  74. Zosel A, "Zolpidem misuse with other medications or alcohol frequently results in intensive care unit admission", Am J Ther, 18, pp.305~308 (2011)
  75. Salomone A, "Hair analysis of drugs involved in drug-facilitated sexual assault and detection of zolpidem in a suspected case", Int J Legal Med, 126, pp.451~459 (2012)
  76. Nutt D, "Alcohol and the brain. Pharmacological insights for psychiatrists", Br J Psychiatry, 175, pp.114~119 (1999)
  77. Ansseau M, "Psychotic reactions to zolpidem", Lancet, 339, pp.809~ (1992)
  78. Iruela L, "Zolpidem-induced macropsia in anorexic woman", Lancet, 342, pp.443~444 (1993)
  79. Pies RW, "Dose-related sensory distortions with zolpidem", J Clin Psychiatry, 56, pp.35~36 (1995)
  80. Hoyler CL, "Zolpidem-induced agitation and disorganization", Gen Hosp Psychiatry, 18, pp.452~453 (1996)
  81. Nutt DJ, "Addiction : brain mechanisms and their treatment implications", Lancet, 347, pp.31~36 (1996)
  82. Tan KR, "Neural bases for addictive properties of benzodiazepines", Nature, 463, pp.769~774 (2010)
  83. Juszczak GR, "Desensitization of GABAergic receptors as a mechanism of zolpidem-induced somnambulism", Med Hypotheses, 77, pp.230~233 (2011)
  84. Pressman MR, "Sleep driving: sleepwalking variant or misuse of z-drugs?", Sleep Med Rev, 15, pp.285~292 (2011)
  85. Raby WN, "Gabapentin therapy for cocaine cravings", Am J Psychiatry, 157, pp.2058~2059 (2000)
  86. Crockford D, "Gabapentin use in benzodiazepine dependence and detoxification", Can J Psychiatry, 46, pp.287~ (2001)
  87. Stahl SM, "Mechanism of action of alpha2delta ligands : voltage sensitive calcium channel(VSCC)modulators", J Clin Psychiatry, 65, pp.1033~1034 (2004)
  88. Oulis P, "Pregabalin in zolpidem dependence and withdrawal", Clin Neuropharmacol, 34, pp.90~91 (2011)
  89. Rappa LR, "Detoxification from high-dose zolpidem using diazepam", Ann Pharmacother, 38, pp.590~594 (2004)
  90. Wang LJ, "Zolpidem dependence and withdrawal seizure : report of two cases", Psychiatr Danub, 23, pp.76~78 (2011)
  91. Haji Seyed Javadi SA, "Zolpidem dependency and withdrawal seizure : a case report study", Iran Red Crescent Med J, 16, pp.e19926~ (2014)
  92. Chen SC, "Detoxification of high-dose zolpidem using cross-titration with an adequate equivalent dose of diazepam", Gen Hosp Psychiatry, 34, pp.210~ (2012)
  93. Cardinali DP, "Assessing the efficacy of melatonin to curtail benzodiazepine", Z drug abuse, 2016, pp.109, 12~23
  94. Kim HM, "Predictors of long-term and high-dose use of zolpidem in veterans", J Clin Psychiatry, 80, pp.18~ (2019)
  95. Gericke CA, "Chronic abuse of zolpidem", JAMA, 272, pp.1721~1722 (1994)
  96. Chien C, "Zolpidem withdrawal delirium, seizure, and acute psychosis : case reports and literature review", J Subst Use, 16, pp.330~338 (2011)
  97. Hsu WY, "Intravenous zolpidem injection in a zolpidem abuser", Pharmacopsychiatry, 46, pp.121~122 (2013)
  98. Majumder U, "Zolpidem dependence with frontal lobe syndrome : a case report", Int J Basic Clin Pharmacol, 6, pp.2936~2938 (2017)
  99. Cubała WJ, "Seizure following sudden zolpidem withdrawal", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.539~540 (2007)
  100. Askew JP, "Zolpidem addiction in a pregnant woman with a history of second-trimester bleeding", Pharmacotherapy, 27, pp.306~308 (2007)
  101. Cubała WJ, "Zolpidem abuse, dependence and withdrawal syndrome : sex as susceptibility factor for adverse effects", Br J Clin Pharmacol, 65, pp.444~445 (2008)
  102. Aragona M, "Abuse, dependence, and epileptic seizures after zolpidem withdrawal : review and case report", Clin Neuropharmacol, 23, pp.281~283 (2000)
  103. Ravishankar A, "Zolpidem tolerance and dependence--two case reports", J Psychopharmacol, 12, pp.103~104 (1998)

관련 논문AI추천

이 간행물의 다른 논문 (19건)